ArticleJournal of agricultural and food chemistry2026
Oosporein in Phlebia centrifuga: Prediction of Key Enzymes by a Combination of Multi-Omics and Molecular Dynamics.
Article in Journal of agricultural and food chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The red bibenzoquinone oosporein, a promising biocontrol agent with potential to replace conventional pesticides in insect pest management in crops, was produced by the Basidiomycota Phlebia centrifuga P. Karst isolated from the Black Forest National Park. A submerged system was established, yielding up to 1.60 g L-1 oosporein in the culture supernatant upon supplementation with the key intermediate orsellinic acid, which strongly induced oosporein-specific biosynthetic genes. Using a multiomics approach, genes encoding enzymes for all necessary conversions were predicted, including a type I polyketide synthase, two monooxygenases, and a heme peroxidase. Enzymatic functions were investigated by extensive docking analyses and molecular dynamics simulations, ultimately leading to the prediction of the underlying biosynthetic pathway. In summary, a spore-free, high-yield, scalable production platform for oosporein was established, highlighting the potential of rare, protected fungal species as sources for valuable enzymes and bioactive secondary metabolites for efficient microbial biomanufacturing systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.